Business Description
Globus Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US3795772082
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 1.5 | |||||
Interest Coverage | 78.21 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.85 | |||||
Beneish M-Score | -1.81 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.5 | |||||
3-Year EBITDA Growth Rate | 19.6 | |||||
3-Year EPS without NRI Growth Rate | 10.8 | |||||
3-Year FCF Growth Rate | 2.5 | |||||
3-Year Book Growth Rate | 24.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 16.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 22.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.57 | |||||
9-Day RSI | 36.35 | |||||
14-Day RSI | 39.61 | |||||
6-1 Month Momentum % | 9.62 | |||||
12-1 Month Momentum % | -11.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.88 | |||||
Quick Ratio | 2.72 | |||||
Cash Ratio | 1.32 | |||||
Days Inventory | 360.71 | |||||
Days Sales Outstanding | 77.89 | |||||
Days Payable | 33.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11 | |||||
Shareholder Yield % | -7.56 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.05 | |||||
Operating Margin % | 12.87 | |||||
Net Margin % | 7.83 | |||||
FCF Margin % | 10.53 | |||||
ROE % | 4.41 | |||||
ROA % | 3.64 | |||||
ROIC % | 5.47 | |||||
ROC (Joel Greenblatt) % | 18.86 | |||||
ROCE % | 6.48 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 43.21 | |||||
Forward PE Ratio | 19.13 | |||||
PE Ratio without NRI | 22.41 | |||||
Shiller PE Ratio | 33.26 | |||||
Price-to-Owner-Earnings | 214.63 | |||||
PEG Ratio | 2.61 | |||||
PS Ratio | 3.75 | |||||
PB Ratio | 1.72 | |||||
Price-to-Tangible-Book | 4.21 | |||||
Price-to-Free-Cash-Flow | 36.45 | |||||
Price-to-Operating-Cash-Flow | 24.37 | |||||
EV-to-EBIT | 33.79 | |||||
EV-to-Forward-EBIT | 20.18 | |||||
EV-to-EBITDA | 19.68 | |||||
EV-to-Forward-EBITDA | 14.98 | |||||
EV-to-Revenue | 4.35 | |||||
EV-to-Forward-Revenue | 2.77 | |||||
EV-to-FCF | 41.29 | |||||
Price-to-Projected-FCF | 1.42 | |||||
Price-to-DCF (Earnings Based) | 1.87 | |||||
Price-to-DCF (FCF Based) | 2.53 | |||||
Price-to-Median-PS-Value | 0.64 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.16 | |||||
Price-to-Graham-Number | 2.05 | |||||
Price-to-Net-Current-Asset-Value | 8.33 | |||||
Earnings Yield (Greenblatt) % | 2.96 | |||||
FCF Yield % | 2.41 | |||||
Forward Rate of Return (Yacktman) % | 13.06 |